Traditional Chinese Medicine ZHENG and OMICS Convergence: A Systems Approach to Post-Genomics Medicine in a Global World
- 1 September 2013
- journal article
- review article
- Published by SAGE Publications in OMICS: A Journal of Integrative Biology
- Vol. 17 (9) , 451-459
Abstract
Traditional Chinese medicine (TCM) is a comprehensive system of medical practice that has been used to diagnose, treat, and prevent illnesses for more than 3000 years. ZHENG (also known as “syndrome”) differentiation remains the essence of TCM. In China, TCM shares equal status, and integrated with Western medicine in the healthcare system to treat many types of diseases. Yet, compared to biomolecular science and Western medicine, the ZHENG/TCM approach to diagnostics might appear unobjective, but offers at the same time long-standing clinical and phenotypic-rich insights. With the current globalization of life sciences and the arrival of “Big Data” research and development, these two silos of medical lore are rapidly coalescing. The applications of multi-omics strategies to TCM have begun to provide novel insights into the essence and molecular basis of TCM ZHENG. We searched the Chinese electronic databases and PubMed for published articles related to “Omics” and “TCM ZHENG” and observed a dramatic increase in studies over the past few years. In this article, we provide a timely synthesis of the lessons learned, and the emerging applications of omics science in TCM ZHENG research. We suggest that the global health scholarship and the field of “developing world Omics” can usefully draw from TCM, and vice versa.Keywords
This publication has 40 references indexed in Scilit:
- Omic techniques in systems biology approaches to traditional Chinese medicine research: Present and futureJournal of Ethnopharmacology, 2012
- Tumor Microenvironment Varies under Different TCMZHENGModels and Correlates with Treatment Response to Herbal MedicineEvidence-Based Complementary and Alternative Medicine, 2012
- Clinical Distribution and Molecular Basis of Traditional Chinese MedicineZHENGin CancerEvidence-Based Complementary and Alternative Medicine, 2012
- The first decade of MALDI protein profiling: A lesson in translational biomarker researchJournal of Proteomics, 2011
- Biomarkers in the Age of Omics: Time for a Systems Biology ApproachOMICS: A Journal of Integrative Biology, 2011
- Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluationJournal of Ethnopharmacology, 2010
- The Molecular Mechanisms of Traditional Chinese Medicine ZHENG Syndromes on Pancreatic Tumor GrowthIntegrative Cancer Therapies, 2010
- Use of Transcriptomics in Understanding Mechanisms of Drug-Induced ToxicityPharmacogenomics, 2010
- Insufficient Activity of MAPK Pathway Is a Key Monitor of Kidney-Yang Deficiency SyndromeThe Journal of Alternative and Complementary Medicine, 2009
- Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomicsFEBS Letters, 2000